← FDA DRUG APPROVALS
FDA ANDA · ANDA040283
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
Sponsor: OXFORD PHARMS
APPLICATION
ANDA040283
TYPE
ANDA
ORIGINAL APPROVAL
1998-12-29
LATEST ACTION
2017-08-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATEDiscontinued
ASPIRIN 325MG, CARISOPRODOL 200MG, CODEINE PHOSPHATE 16MG · TABLET · ORAL
Approval history
2017-08-29Labeling · Supplement 10 · standardAP
2008-02-25Labeling · Supplement 5AP
1999-04-30Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.